New reports from The United Kingdom on health has it that, Dexamethasone drug is approved for the
treatment of Covid-19.
Dexamethasone is the first drug that has proven to increase the survival rate for hospitalised Covid-19 patients
ALSO READ : Health workers accounting for 97 Ashanti Infected covid-19
The drug is a steroid is given either as a tablet or an injection costing only £5 per patient.
Scientists have hailed the finding as ‘biggest breakthrough in search for Covid19 therapy’ after mixed
results from others.
Oxford Professor, Peter Horby who led the British trail said a life could be saved with every eight
patients.
ALSO READ : COVID-19: Ghana’s death toll hits 66 with 12,590 confirmed cases
He said the drug could save up to 35 per cent of patients relying on ventilators – the most dangerously
ill – and reduce the odds of death by a fifth for all patients needing oxygen at any point.
UK Prime Minister Boris Johnson also hailed the finding as the ‘biggest breakthrough yet’ in the UK’s
coronavirus fight.
“I’m absolutely delighted that the biggest breakthrough yet has been made by a fantastic team of
scientists right here in the UK… I think there is genuine cause to celebrate a remarkable British
scientific achievement [and] the benefits it will bring not just in this country but around the world, ” he
said at a press conference.
ALSO READ : Popular fetish Togbe Shitor, Arrested along with two others for faking death
Dexamethasone, first created in the 1950s, is usually given to treat ulcerative colitis, arthritis and some
types of cancer.
It is already licensed and proven to be safe, meaning it can be used in human patients immediately, and
is a generic drug, meaning it can be manufactured cheaply and en masse by companies all over the
world.
